{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:20Z","timestamp":1791994580561,"version":"4.4.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100015756","name":"Janssen-Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"abstract":"<jats:p>We report promising clinical outcomes using ustekinumab as a first-line therapy in bullous pemphigoid when combined with a short, 8-week regimen of superpotent topical corticosteroids. Furthermore, the CD40 ligand\/interleukin-4 ratio emerged as a potential predictive biomarker of treatment response, possibly reflecting a T helper 1-skewed immune environment that favours ustekinumab\u2019s mechanism of action.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf354","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:46:32Z","timestamp":1757159192000},"page":"1257-1260","source":"Crossref","is-referenced-by-count":2,"title":["Ustekinumab as a potential therapeutic agent in bullous pemphigoid: a biologic and clinical proof-of-concept study"],"prefix":"10.1093","volume":"193","author":[{"given":"Vlada","family":"Koliadenko","sequence":"first","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0255","authenticated-orcid":false,"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Dermatology, and INSERM U1234 Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL and ERN), Normandie University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6772-5191","authenticated-orcid":false,"given":"Flora","family":"Lemaire","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-7096","authenticated-orcid":false,"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Henri-Mondor Hospital, Department of Dermatology , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-3691","authenticated-orcid":false,"given":"Christophe","family":"Bedane","sequence":"additional","affiliation":[{"name":"CHU Limoges \u2013 Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Limoges ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9552-0882","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Caux","sequence":"additional","affiliation":[{"name":"Avicenne University Hospital, Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Bobigny ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lopes","sequence":"additional","affiliation":[{"name":"University Hospital of Reims, Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-4842","authenticated-orcid":false,"given":"Delphine","family":"Giusti","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]},{"name":"University Hospital of Reims, Department of Immunology , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Muller","sequence":"additional","affiliation":[{"name":"University Hospital of Reims, Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-010X","authenticated-orcid":false,"given":"Billal","family":"Tedbirt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, and INSERM U1234 Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL and ERN), Normandie University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-9625","authenticated-orcid":false,"given":"Cl\u00e9lia","family":"Vanhaecke","sequence":"additional","affiliation":[{"name":"University Hospital of Reims, Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-6041","authenticated-orcid":false,"given":"Richard","family":"Le Naour","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3068-8769","authenticated-orcid":false,"given":"St\u00e9phane","family":"Potteaux","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]},{"name":"D\u00e9partement de Recherche, Institut Godinot , Reims ,","place":["France"]},{"name":"Inserm, D\u00e9l\u00e9gation R\u00e9gionale Paris \u00cele-de-France Centre Nord , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-2855","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Le Jan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-8700","authenticated-orcid":false,"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Reims Champagne Ardenne , IRMAIC UR7509, Reims ,","place":["France"]},{"name":"University Hospital of Reims, Department of Dermatology, Reference Center for Rare Diseases (Autoimmune Bullous Disorders \u2013 MALIBUL) , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2025111813172625700_ljaf354-B1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2\u2005K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025111813172625700_ljaf354-B2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2025111813172625700_ljaf354-B3","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/srep18001","article-title":"Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome","volume":"5","author":"Pl\u00e9e","year":"2015","journal-title":"Sci Rep"},{"key":"2025111813172625700_ljaf354-B4","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1111\/jdv.14002","article-title":"A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis","volume":"31","author":"Loget","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025111813172625700_ljaf354-B5","doi-asserted-by":"crossref","first-page":"1050373","DOI":"10.3389\/fimmu.2022.1050373","article-title":"Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"2025111813172625700_ljaf354-B6","doi-asserted-by":"crossref","first-page":"1171802","DOI":"10.3389\/fmed.2023.1171802","article-title":"Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report\u00a0and\u00a0literature review","volume":"10","author":"Kong","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2025111813172625700_ljaf354-B7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.abd.2023.07.017","article-title":"Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab","volume":"99","author":"Rodr\u00edguez-Cuadrado","year":"2024","journal-title":"An Bras Dermatol"},{"key":"2025111813172625700_ljaf354-B8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00403-025-04052-x","article-title":"A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects","volume":"317","author":"Heidari","year":"2025","journal-title":"Arch Dermatol Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf354\/64356652\/ljaf354.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/6\/1257\/64356652\/ljaf354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/6\/1257\/64356652\/ljaf354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T18:17:32Z","timestamp":1763489852000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/6\/1257\/8262622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,17]]},"published-print":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf354","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,17]]}}}